A Prospective, Multicenter, Randomized, Open-label, Comparative Study in Three Parallel Groups to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone (Femoston 1 or Femoston 2, Coated Tablets) and the Combination Therapy of Dydrogesterone (Duphaston, Coated Tablets) Plus Estradiol (Divigel, Gel for Topical Application, 0.1%) and Monotherapy With Cimicifuga Racemosa Rhizomatum Extract (Klimadynon) in Perimenopausal Women
Latest Information Update: 07 Dec 2023
At a glance
- Drugs Estradiol/dydrogesterone (Primary) ; Cimicifuga; Dydrogesterone; Estradiol
- Indications Hot flashes
- Focus Therapeutic Use
- 16 Dec 2021 New trial record